Entegris, Inc.

  • Market Cap: Small Cap
  • Industry: Industrial Manufacturing
  • ISIN: US29362U1043
USD
88.14
8.32 (10.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Entegris, Inc. stock-summary
stock-summary
Entegris, Inc.
Industrial Manufacturing
Entegris, Inc. is a global developer, manufacturer and supplier of microcontamination control products, specialty chemicals and materials handling solutions for manufacturing processes in the semiconductor and other high-technology industries. The Company operates in three business segments: Specialty Chemicals and Engineered Materials (SCEM), Advanced Materials Handling (AMH) and Microcontamination Control (MC). The SCEM segment provides process chemistries, gases, materials and delivery systems to support semiconductor and other manufacturing processes. The AMH segment develops solutions to monitor, protect, transport, and deliver critical liquid chemistries and substrates for a set of applications in the semiconductor industry and other high-technology industries. AMH offers wafer solutions, chemical containers and fluidics. MC offers solutions to purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Company Coordinates stock-summary
Company Details
129 Concord Rd , BILLERICA MA : 01821-4600
stock-summary
Tel: 1 978 43665001 952 952 556 18
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 127 Schemes (49.37%)

Foreign Institutions

Held by 282 Foreign Institutions (23.78%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Paul Olson
Independent Chairman of the Board
Mr. Bertrand Loy
President, Chief Executive Officer, Director
Mr. Michael Bradley
Independent Director
Amb. R. Nicholas Burns
Independent Director
Mr. James Gentilcore
Independent Director
Mr. James Lederer
Independent Director
Dr. Azita Saleki-Gerhardt
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
792 Million
(Quarterly Results - Jun 2025)
Net Profit:
53 Million
stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

USD 12,469 Million (Small Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

24.32%

stock-summary
Debt Equity

0.95

stock-summary
Return on Equity

7.72%

stock-summary
Price to Book

3.27